✦ LIBER ✦

Oestrogen exposure and breast cancer risk

✍ Scribed by Ruth C Travis, Timothy J Key

Book ID: 120701121
Publisher: BioMed Central
Year: 2003
Tongue: English
Weight: 88 KB
Volume: 5
Category: Article
ISSN: 1465-5411
DOI: 10.1186/bcr628

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A polymorphism in the promoter region of

A polymorphism in the promoter region ofKu70/XRCC6, associated with breast cancer risk and oestrogen exposure

✍ Petra Willems; Kim De Ruyck; Rudy Van den Broecke; Amin Makar; Gianpaolo Perlett 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 500 KB

Bone mass and the risk of breast cancer:

Bone mass and the risk of breast cancer: The influence of cumulative exposure to oestrogen and reproductive correlates. Results of the Marburg breast cancer and osteoporosis trial (MABOT)

✍ P. Hadji; M. Gottschalk; V. Ziller; M. Kalder; C. Jackisch; U. Wagner 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 335 KB

Combined oestrogen-progestogen replaceme

Combined oestrogen-progestogen replacement and breast cancer risk

✍ Persson, Ingemar; Yuen, Jonathan; Bergkvist, Leif; Adami, Hans-Olov; Hoover, Rob 📂 Article 📅 1992 🏛 The Lancet 🌐 English ⚖ 183 KB

Oestrogen binding and risk factors for b

Oestrogen binding and risk factors for breast cancer

✍ Ingram, DM; Nottage, EM; Willcox, DL; Roberts, A 📂 Article 📅 1990 🏛 Nature Publishing Group 🌐 English ⚖ 959 KB

Oestrogens, Oestrogen Receptors and Brea

Oestrogens, Oestrogen Receptors and Breast Cancer

✍ D.J Bentrem; P Gaiha; V.C Jordan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 303 KB

Breast-cancer risk following long-term o

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

✍ Cecilia Magnusson; John A. Baron; Nestor Correia; Reinhold Bergström; Hans-Olov 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 62 KB 👁 2 views

While use of hormone-replacement therapy (HRT) effectively alleviates menopausal symptoms and prevents osteoporosis and possibly cardiovascular disease, there is concern of a detrimental impact on breast-cancer risk. There is a particular lack of data regarding the effect of long-term use of oestrog